Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Funding incremental working capital requirements
Augmenting working capital resources to support business expansion and inventory management.
General corporate purposes
Funding strategic initiatives, brand building, and general corporate operational expenses.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Nureca Limited is a B2C digital-first home healthcare and wellness products company in India, incorporated in October 2016. The company designs, develops, manufactures, and markets medical devices, monitoring equipment, and lifestyle products primarily under its flagship brand Dr Trust, alongside complementary brands such as Dr Physio and Trumom. The company offers a diversified portfolio of home healthcare products spanning chronic disease monitoring devices (including blood pressure monitors, pulse oximeters, blood glucose monitors, and nebulizers), orthopedic supports, medical wearables, personal care electronics, and nutritional supplements. Nureca operates through an online-first omnichannel strategy, distributing products through major e-commerce marketplaces such as Amazon, Flipkart, and Nykaa as well as its own direct-to-consumer platform. Capitalizing on expanding health awareness and home-based healthcare trends across India, Nureca operates an asset-light business model by utilizing third-party contract manufacturers while maintaining control over brand management, product design, quality assurance, and customer service. Supported by strong financial return metrics, the company continues to deepen its market presence in consumer medical devices.
Nureca Limited raised Rs 44.55 crore from 2 anchor investors on February 12, 2021, allocating 11,13,750 equity shares at the cap price of Rs 400 per share. The anchor portion was subscribed by Nexpact Ltd (Rs 34.55 crore) and Next Orbit Ventures Fund (Rs 10.00 crore).
Source: RHP • Analysis provided for informational purposes
Last Updated: 28 July 2026, 7:21 AM
Strong Brand Recognition in Home Healthcare
Built a leading position in chronic disease monitoring and consumer health devices under its flagship Dr Trust brand.
Asset-Light Digital-First Model
Leverages direct-to-consumer channels and major e-commerce platforms alongside contract manufacturing for capital efficiency.
High Return Metrics and Profitability
Maintains strong profit margins and high return on net worth driven by direct consumer access and a scalable operating structure.
Diversified Product Suite
Offers a comprehensive range of preventive, diagnostic, and monitoring devices catering to growing home healthcare needs.
Dependence on Third-Party E-Commerce Marketplaces
Relies heavily on external online platforms for customer acquisition and product sales, creating vulnerability to platform policy updates.
Outsourced Manufacturing Operations
Relies on third-party contract manufacturers for production, exposing operations to potential supply chain disruptions or quality issues.
Intense Market Competition
Faces competition from established global medical device brands and low-cost domestic importers in the consumer health equipment sector.
Nureca Limited
Office No. 101, 1st Floor, Udyog Bhavan, Sonawala Lane, Goregaon (East), Mumbai - 400063, Maharashtra, India
View on Maps →MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.